Anti-Argonaute-2 antibody [2E12-1C9] - BSA and Azide free,Abcam,AB57113

What is this antibody validated in? Anti-Argonaute-2 antibody [2E12-1C9] - BSA and Azide free (ab57113) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, samples. What is the molecular weight of Argonaute-2? Anti-Argonaute-2 [2E12-1C9] - BSA and Azide free (ab57113) specifically detects a band for Argonaute-2 (UniProt: Q9UKV8) at a molecular weight of 97kDa. Trusted by the scientific community Anti-Argonaute-2 [2E12-1C9] - BSA and Azide free (ab57113) was first used in a scientific publication in 2007 and has been cited over 160 times in peer-reviewed journals. Reviewed by scientists Anti-Argonaute-2 [2E12-1C9] - BSA and Azide free (ab57113) has over 5 independent reviews from customers.

Host

Mouse

Reactivity

Human

Application

Flow Cyt, IHC-P, WB, ICC/IF

Platform ID

BAB902534835

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameAnti-Argonaute-2 antibody [2E12-1C9] - BSA and Azide free
Cat. No.AB57113
HostMouse
IsotypeIgG1
ReactivityHuman
ApplicationFlow Cyt, IHC-P, WB, ICC/IF
ClonalityMonoclonal
Clone Number2E12-1C9
Concentration0.21 - 0.5 mg/mL Batch dependent concentration
ImmunogenRecombinant Fragment Protein within Human AGO2 aa 450 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Constituents: PBS
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions.. (Microbial infection) Upon Sars-CoV-2 infection, associates with viral miRNA-like small RNA, CoV2-miR-O7a, and may repress mRNAs, such as BATF2, to evade the IFN response. See full target information AGO2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.